Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Spex Capital is an investment management firm founded by Claudio D’Angelo, focusing on early-stage ventures in the digital technology sector. Established in England and Wales, the firm is authorized and regulated by the Financial Conduct Authority. Spex Capital aims to support and invest in companies that are working to commercialize and scale innovative technologies globally.
The firm operates the Spex Venture Health-Tech Fund, a €100 million global fund dedicated to identifying and partnering with early-stage digital healthcare and med-tech startups. Currently, Spex Capital manages assets totaling €100 million and has invested in seven companies, reflecting a commitment to advancing the healthcare sector through technology.
Notable milestones include a total investment of €29 million across its portfolio, which has achieved a current valuation exceeding €190 million. This demonstrates the firm's effective investment strategy and its ability to identify promising ventures in the healthtech space.
Spex Capital specializes in early-stage investments in digital technologies, particularly within the healthcare sector. The firm has launched the €100 million Spex Venture Health-Tech Fund, targeting early-stage digital healthcare and med-tech startups. Investment sizes typically range from €500,000 to €2 million at the seed stage, with the potential to invest up to €5 million at Series A. For companies they are familiar with, Spex Capital may also consider follow-on investments in Series B.
The firm seeks companies that demonstrate traction, such as existing contracts, revenues, or strategic partnerships. This focus on validated business models allows Spex Capital to mitigate risks while supporting ventures that are poised for growth. The firm emphasizes a multidisciplinary investment approach, leveraging its team's extensive experience in financial, digital, and medical industries to provide strategic guidance and support.
Spex Capital currently has a portfolio of seven companies, all of which focus on healthtech investments. The firm has invested a total of €29 million in these companies, which collectively hold a current valuation of over €190 million. This portfolio reflects Spex Capital's commitment to advancing innovative technologies in the healthcare sector.
While specific company names and outcomes are not detailed in the provided data, the emphasis on healthtech indicates a strategic alignment with the growing demand for digital healthcare solutions. The firm's multidisciplinary investment approach allows it to leverage expertise across financial, digital, and medical fields to support the growth of its portfolio companies.
Claudio D'Angelo - General Partner. Claudio has extensive experience in investment management and has led numerous successful ventures in the digital technology sector.
Lord Nick Markham - General Partner. Nick brings a wealth of knowledge from his background in healthcare and technology investments, contributing to the firm's strategic direction.
Diva Tommei - General Partner. Diva has a strong track record in venture capital, focusing on early-stage investments in innovative technologies.
Brent Stackhouse - General Partner. Brent specializes in financial analysis and has a keen eye for identifying promising startups in the healthtech space.
Filippo Falaschi - General Partner. Filippo's expertise lies in digital health, where he has successfully guided several startups through their growth phases.
Dénes Csiszar - General Partner. Dénes has a background in medical technology and provides valuable insights into the firm's investment decisions.
Nikolett Fohsz - Analyst. Nikolett supports the investment team with market research and analysis of potential portfolio companies.
Ana González Plaza - Analyst. Ana focuses on due diligence and assists in evaluating investment opportunities.
Elisabetta Trasatti - Analyst. Elisabetta contributes to the firm's research efforts, analyzing trends in the healthcare sector.
Jo Pisani - Senior Advisor. Jo provides strategic advice based on his extensive experience in healthcare investments.
Dr. Fiona Adshead - Senior Advisor. Fiona offers insights into health policy and digital health innovations.
Dr. Stephanie Kuku - Senior Advisor. Stephanie specializes in medical technology and supports the firm's investment strategy.
Keith George Gibbs - Senior Advisor. Keith brings expertise in venture capital and healthcare, enhancing the firm's advisory capabilities.
Arjun Agarwal - Senior Advisor. Arjun has a background in technology investments and provides guidance on digital health ventures.
Avi Lasarow - Senior Advisor. Avi focuses on scaling healthtech startups and offers operational support to portfolio companies.
Linnar Viik - Senior Advisor. Linnar's expertise in digital transformation aids the firm's investment decisions.
Agota Nika - Senior Advisor. Agota provides insights into market trends and investment opportunities in healthcare.
Kwame Amaning - Expert Advisor. Kwame specializes in financial modeling and analysis for startups.
Johann Huber - Expert Advisor. Johann offers strategic insights based on his experience in venture capital.
Veronika Kuchinskiy - Expert Advisor. Veronika supports the firm with market research and analysis.
Julian Pittam - Expert Advisor. Julian provides guidance on investment strategies and portfolio management.
Bradley Hardiman - Expert Advisor. Bradley focuses on operational support for healthtech startups.
To pitch to Spex Capital, founders should send an email to team@spexcapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and traction. Founders should expect a response within a few weeks, depending on the volume of inquiries.
Warm introductions are preferred, as they can facilitate a more favorable review process. The pitch deck should clearly articulate the startup's value proposition, competitive landscape, and financial projections to capture the attention of the investment team.
As of March 2023, Spex Capital has actively invested in the digital health sector, maintaining a portfolio of seven companies with a total investment of €29 million. The firm emphasizes a multidisciplinary approach to investment, leveraging its team's extensive experience in financial, digital, and medical industries.
Recent activities include the ongoing management of the Spex Venture Health-Tech Fund, which has a total size of €100 million. The firm continues to seek promising early-stage digital healthcare and med-tech startups for potential investment.
What are Spex Capital's investment criteria?
Spex Capital focuses on early-stage digital healthcare and med-tech startups. The firm typically invests between €500,000 to €2 million at the seed stage and up to €5 million at Series A. They look for companies with demonstrated traction, such as contracts, revenues, or partnerships.
How can I apply or pitch to Spex Capital?
Founders can reach out to Spex Capital via email at team@spexcapital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and traction.
What makes Spex Capital different from other investors?
Spex Capital emphasizes a multidisciplinary investment approach, leveraging extensive experience in financial, digital, and medical industries. This allows them to provide strategic guidance and support to portfolio companies, helping them scale and commercialize their technologies effectively.
What is the geographic scope of Spex Capital's investments?
The firm primarily focuses on investments in Europe, particularly in the United Kingdom, aligning with its operational base and expertise in the region.
What is Spex Capital's post-investment involvement like?
Spex Capital actively engages with its portfolio companies, providing strategic guidance and support to help them navigate challenges and scale their operations. Their team’s diverse expertise allows them to add significant value beyond capital investment.
What is the size of Spex Capital's fund?
Spex Capital operates the Spex Venture Health-Tech Fund, which has a total size of €100 million, dedicated to investing in early-stage digital healthcare ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.